Page last updated: 2024-09-05

cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) and Heart Disease, Ischemic

cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) has been researched along with Heart Disease, Ischemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cioffi, MA; Forbess, J; Hiramatsu, T; Mayer, JE; Miura, T; Roth, SJ1

Other Studies

1 other study(ies) available for cyclo(glutamyl-alanyl-isoleucyl-leucyl-tryptophyl) and Heart Disease, Ischemic

ArticleYear
Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
    Circulation, 1995, Nov-01, Volume: 92, Issue:9 Suppl

    Topics: Animals; Biological Assay; Coronary Circulation; Endothelin Receptor Antagonists; Endothelins; Heart; Heart Arrest, Induced; Hypothermia, Induced; Myocardial Ischemia; Oxygen Consumption; Peptides, Cyclic; Receptor, Endothelin A; Reference Values; Sheep; Ventricular Function, Left

1995